PL3760190T3 - Tabletki pregabaliny o kontrolowanym uwalnianiu, sposób wytwarzania i sposób ich zastosowania - Google Patents

Tabletki pregabaliny o kontrolowanym uwalnianiu, sposób wytwarzania i sposób ich zastosowania

Info

Publication number
PL3760190T3
PL3760190T3 PL20172176.8T PL20172176T PL3760190T3 PL 3760190 T3 PL3760190 T3 PL 3760190T3 PL 20172176 T PL20172176 T PL 20172176T PL 3760190 T3 PL3760190 T3 PL 3760190T3
Authority
PL
Poland
Prior art keywords
pregabalin
making
controlled
release tablets
tablets
Prior art date
Application number
PL20172176.8T
Other languages
English (en)
Inventor
Zhen MEI
Amit Shah
Mayank Joshi
Raghav K. Gupta
Original Assignee
Alvogen, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alvogen, Inc. filed Critical Alvogen, Inc.
Publication of PL3760190T3 publication Critical patent/PL3760190T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL20172176.8T 2019-07-03 2020-04-29 Tabletki pregabaliny o kontrolowanym uwalnianiu, sposób wytwarzania i sposób ich zastosowania PL3760190T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962870121P 2019-07-03 2019-07-03

Publications (1)

Publication Number Publication Date
PL3760190T3 true PL3760190T3 (pl) 2023-09-04

Family

ID=70480166

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20172176.8T PL3760190T3 (pl) 2019-07-03 2020-04-29 Tabletki pregabaliny o kontrolowanym uwalnianiu, sposób wytwarzania i sposób ich zastosowania

Country Status (10)

Country Link
US (1) US11974974B2 (pl)
EP (1) EP3760190B1 (pl)
BR (1) BR102020013422A2 (pl)
DK (1) DK3760190T3 (pl)
ES (1) ES2953059T3 (pl)
FI (1) FI3760190T3 (pl)
HU (1) HUE063492T2 (pl)
PL (1) PL3760190T3 (pl)
PT (1) PT3760190T (pl)
RS (1) RS64394B1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115721600B (zh) * 2022-11-10 2025-08-22 济川(上海)医学科技有限公司 一种胃滞留型普瑞巴林缓释组合物及其制备方法
GB2624861A (en) * 2022-11-28 2024-06-05 Orbit Pharma Ltd Sustained release pharmaceutical compositions comprising pregabalin or pharmaceutically acceptable salts thereof
CN116898819B (zh) * 2023-06-09 2024-02-06 则正(上海)生物科技有限公司 一种普瑞巴林缓释剂及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2781793B1 (fr) * 1998-08-03 2001-07-20 Prographarm Lab Procede de fabrication de granules de gabapentine enrobes
NL2000281C2 (nl) 2005-11-02 2007-08-07 Pfizer Prod Inc Vaste farmaceutische samenstellingen die pregabaline bevatten.
ATE511392T1 (de) 2007-01-11 2011-06-15 Xenoport Inc Verzögert freigesetzte orale dosierungsformen eines prodrugs von r-baclofen und behandlungsverfahren damit
RU2012100709A (ru) 2009-06-12 2013-07-20 Майкро Лэбз Лимитед Новые фармацевтические композиции, содержащие прегабалин
WO2010150221A1 (en) 2009-06-25 2010-12-29 Wockhardt Research Centre Taste masked pharmaceutical compositions of pregabalin
KR101317592B1 (ko) 2009-10-28 2013-10-15 씨제이제일제당 (주) 프레가발린, 폴리에틸렌옥사이드 및 폴리비닐알코올-폴리에틸렌글리콜 그라프트 공중합체를 함유하는 위체류형 서방성 제제
US20130078290A1 (en) * 2010-06-01 2013-03-28 Rubicon Research Private Limited Gastroretentive Dosage Forms Of GABA Analogs
EP2590636A1 (en) 2010-07-06 2013-05-15 Grünenthal GmbH Novel gastro- retentive dosage forms comprising a gaba analog and an opioid
IN2014DN06965A (pl) * 2012-01-30 2015-04-10 Ranbaxy Lab Ltd
KR101269829B1 (ko) 2012-04-27 2013-05-30 씨제이제일제당 (주) 위체류 약물전달 시스템을 이용한 서방성 제제
CA2888278A1 (en) * 2012-10-15 2014-04-24 Isa Odidi Oral drug delivery formulations
US9861585B2 (en) 2012-10-16 2018-01-09 Sun Pharmaceutical Industries Limited Osmotic floating tablets
WO2015114509A1 (en) 2014-01-28 2015-08-06 Ranbaxy Laboratories Limited Stabilized gastroretentive tablets of pregabalin
WO2015157138A1 (en) * 2014-04-07 2015-10-15 Banner Life Sciences Llc Abuse-deterrent controlled release formulations

Also Published As

Publication number Publication date
PT3760190T (pt) 2023-07-31
HUE063492T2 (hu) 2024-01-28
US20210000775A1 (en) 2021-01-07
BR102020013422A2 (pt) 2021-01-12
EP3760190A1 (en) 2021-01-06
ES2953059T3 (es) 2023-11-07
DK3760190T3 (da) 2023-09-04
EP3760190B1 (en) 2023-05-24
RS64394B1 (sr) 2023-08-31
FI3760190T3 (fi) 2023-08-09
US11974974B2 (en) 2024-05-07

Similar Documents

Publication Publication Date Title
IL288467A (en) Preparation of a parp inhibitor pill and a method for its preparation
EP3868367A4 (en) Micro-effervescent buccal tablet and preparation method thereof
SG11202106861UA (en) Lash extensions and methods of manufacture and use thereof
CA189959S (en) Bracelet
GB2593334B (en) Plant Soft Capsule and Preparation Method and Application Thereof
CA205951S (en) Earring
CA205952S (en) Earring
GB2572610B (en) Composition, methods for its production, and its use
IL276871A (en) Pure bupropion dosage forms and methods for enantiomeric distortion purposes
GB201903787D0 (en) Microcapsules containing curcumin, and methods for the production thereof
SG11202103677PA (en) Low-halogen underfiller, preparation method therefor and application thereof
PT3760190T (pt) Comprimidos de libertação controlada de pregabalina, método de preparação e método de utilização dos mesmos
SG11202106282RA (en) Biochip, method of preparation and use thereof
GB2584018B (en) Root-level application selective configuration
ZA202108300B (en) Sustained-release microparticles containing deslorelin, and preparation method therefor
SG11202106839XA (en) Cellulose powder, use thereof, and tablets
PL3661508T3 (pl) Sposób wytwarzania doustnej postaci dawkowania zawierającej berberynę, doustna postać dawkowania zawierająca berberynę i jej zastosowanie
IL289586A (en) pi4kiii alpha micromolecule inhibiting preparation, method for its preparation and use
ZA201906973B (en) Photocatalytic gel and preparation method thereof
GB2595141B (en) Flupentixol melitracen tablet and preparation method therefor
ZA202110948B (en) Pharmaceutical dosage forms and methods for their production
PL3960240T3 (pl) Preparat farmaceutyczny i sposób jego wytwarzania
IL291514A (en) Preparations containing a pure enantiomer or enantiomer enriched of bupropion and methods of using these preparations
IL290627A (en) Nutritional powder production process through micronization, and powder composition
HUE069293T2 (hu) Készítmény, elõállítási eljárása és alkalmazása